Global FES Leader Restorative Therapies, Inc is a global leader in integrated Functional Electrical Stimulation (FES) technology with an established clinical evidence base and a broad customer base across rehabilitation hospitals, outpatient clinics, long-term care facilities, and home health providers, presenting multiple channels for upsell and cross-sell of RT300 and Xcite2 systems.

Expanding Markets Recent product launches and market expansion in Korea (RT300 and Xcite2 introduced at KIMES) indicate international growth momentum and opportunities to pursue hospital networks, rehab centers, and government procurement paths in new regions.

Clinical Adoption A strong emphasis on clinician training, reimbursement support, and data-driven outcomes positions the company to offer value-added services, training packages, and payer negotiation support to new facilities adopting FES therapy.

Partnership Leverage Existing partnerships with clinicians, researchers, and payers, plus collaborations like United Spinal Association discounts, suggest opportunities to expand alliances, bundled offerings, and channel partnerships to drive adoption and loyalty.

Security and Resilience Upcoming attention is needed due to a ransomware incident in May 2026; a sales strategy can emphasize enhanced cybersecurity measures, data protection assurances, and service continuity bundles to reassure customers and mitigate procurement risks.